A striking response to bortezomib in a patient with pleural localization of multiple myeloma.
Silvia
S
Mangiacavalli
Marzia
M
Varettoni
Patrizia
P
Zappasodi
Gianmatteo
G
Pica
Mario
M
Lazzarino
Alessandro
A
Corso
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007150:Immunohistochemistry; D017404:In Situ Hybridization, Fluorescence; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D010994:Pleura / Q000187:drug effects / Q000473:pathology*; D016066:Pleural Effusion, Malignant / Q000188:drug therapy* / Q000209:etiology; D011719:Pyrazines / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed
D000970:Antineoplastic Agents; D001897:Boronic Acids; D007074:Immunoglobulin G; D011719:Pyrazines; D000069286:Bortezomib